Please Wait.....
Report
Vascular Access Devices - Company Evaluation Report, 2024
Market Report I 2025-05-01 I 138 Pages I MarketsandMarkets
The Vascular Access Devices Market Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Vascular Access Devices market . This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 100 companies, of which the Top 25 Vascular Access Devices market Companies were categorized and recognized as the quadrant leaders.
A vascular access device (VAD) is a medical instrument inserted into a vein or artery to provide direct access to the bloodstream for delivering medications, fluids, or nutrients, as well as for drawing blood. Commonly used in long-term treatments like chemotherapy or dialysis, VADs are classified as central or peripheral depending on the site and duration of use. These devices are typically placed in the arm, chest, or leg and can remain in place for extended periods to support ongoing medical care.
The vascular access devices market is expected to grow from USD 5,991.2 million in 2024 to USD 9,057.2 million by 2030, at a CAGR of 7.1%. This growth is primarily driven by increased investment from key industry players and a rising prevalence of conditions that require vascular access. However, a shortage of skilled healthcare professionals may pose a challenge to market expansion.
The 360 Quadrant maps the Vascular Access Devices market companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Vascular Access Devices market quadrant. The top criteria for product footprint evaluation included Type (central venous access devices, peripheral vascular access devices, accessories, intraosseous vascular access devices), By Route of Insertion (intravenous route of insertion, subcutaneous route of insertion, intraosseous route of insertion) By Application (drug administration, fluid & nutrition administration, blood transfusion, diagnostics & testing) By End User (hospitals, clinics & ambulatory care centers, other end users).
Key Players:
Key market players, such Beckton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical (US), Terumo Corporation (Japan), and B Braun SE (Germany), Medtronic (Ireland), Vygon (France), Amecath (Egypt), AngioDynamics (US), Medical Components, Inc. (US), and Nipro (Japan), Merit Medical Systems (US), Health Line International Corporation (US), Medi-Tech Devices Pvt. Ltd. (India), Cook (US), and Argon Medical Devices (US), Access Vascular, Inc. (US), PakuMedmedical Products GmbH (Germany), Guangdong Baihe Medical Technology Co., Ltd. (China), Shanghai Puyi Medical Instruments Co., Ltd. (China), Newtech Medical Devices Pvt. Ltd. (India), DeltaMed (Italy), Kimal (UK), PolyMedicure (India), and PFM Medical GmbH (Germany)
Becton Dickinson and Company (US)
Becton Dickinson, a key player in the vascular access devices market, is renowned for its robust geographic presence and extensive product portfolio that includes central and peripheral venous access catheters. The company's acquisition of C.R. Bard for USD 24 billion significantly enhanced its product portfolio and market share. BD's strong global distribution network supports market stability by mitigating demand fluctuations across various geographies.
Teleflex Incorporated (US)
Teleflex boasts a rich history and extensive experience in the vascular access devices sector. The company markets its products under the Arrow brand and continues to innovate by launching new products, such as the Arrow Pressure Injectable Midline Catheter. These strategic launches have strengthened Teleflex's market position by addressing clinician needs and enhancing patient safety. Teleflex's expansion into regions like Europe and Africa has further solidified its market position.
ICU Medical (US)
ICU Medical's competitive edge lies in its comprehensive product portfolio, featuring central venous catheters, needle-free connectors, and more. The company's 2022 acquisition of Smiths Medical broadened its capabilities in infusion therapy applications, thereby enhancing its global reach and strengthening its market presence. ICU Medical emphasizes high-quality products that meet rigorous regulatory standards, alongside offering training and support to healthcare professionals.
1 INTRODUCTION 12
1.1 MARKET DEFINITION 12
1.2 INCLUSIONS & EXCLUSIONS 12
1.3 STAKEHOLDERS 13
2 EXECUTIVE SUMMARY 14
3 MARKET OVERVIEW 22
3.1 INTRODUCTION 22
3.2 MARKET DYNAMICS 22
3.2.1 DRIVERS 23
3.2.1.1 Growing prevalence of lifestyle diseases 23
3.2.1.2 Increasing popularity of chemotherapy procedures among cancer patients 23
3.2.1.3 Rising use of vascular access devices among pediatric patients 23
3.2.2 RESTRAINTS 24
3.2.2.1 High cost of installation and maintenance of vascular access devices 24
3.2.2.2 Rising product recalls and failures 24
3.2.3 OPPORTUNITIES 25
3.2.3.1 Technological advancements 25
3.2.3.2 Increasing number of hospitals and expanding patient pool 25
3.2.4 CHALLENGES 26
3.2.4.1 Shortage of skilled healthcare professionals 26
3.2.4.2 Risks associated with use of vascular access devices 26
3.3 TECHNOLOGY ANALYSIS 27
3.3.1 KEY TECHNOLOGIES 27
3.3.1.1 Imaging and navigation technologies 27
3.3.1.2 Catheter securement and stabilization technologies 27
3.3.2 COMPLEMENTARY TECHNOLOGIES 27
3.3.2.1 AI and ML 27
3.3.3 ADJACENT TECHNOLOGIES 28
3.3.3.1 Infection control technologies 28
3.4 INDUSTRY TRENDS 28
3.4.1 MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES 28
3.4.2 INNOVATIONS IN CATHETER MATERIALS AND COATINGS 28
3.5 VALUE CHAIN ANALYSIS 29
3.6 ECOSYSTEM ANALYSIS 30
3.6.1 ROLE IN ECOSYSTEM 31
3.7 SUPPLY CHAIN ANALYSIS 31
3.8 PORTER'S FIVE FORCES ANALYSIS 33
3.8.1 THREAT OF NEW ENTRANTS 34
3.8.2 THREAT OF SUBSTITUTES 34
3.8.3 BARGAINING POWER OF BUYERS 34
3.8.4 BARGAINING POWER OF SUPPLIERS 34
3.8.5 INTENSITY OF COMPETITIVE RIVALRY 34
3.9 PATENT ANALYSIS 35
3.9.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 35
3.10 KEY CONFERENCES & EVENTS, 2025-2026 37
3.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS 38
3.12 IMPACT OF AI/GEN AI ON VASCULAR ACCESS DEVICES MARKET 39
4 COMPETITIVE LANDSCAPE 40
4.1 INTRODUCTION 40
4.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 40
4.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
VASCULAR ACCESS DEVICES MARKET 40
4.3 REVENUE ANALYSIS, 2019-2023 42
4.4 MARKET SHARE ANALYSIS, 2023 43
4.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 45
4.5.1 STARS 45
4.5.2 EMERGING LEADERS 45
4.5.3 PERVASIVE PLAYERS 45
4.5.4 PARTICIPANTS 45
4.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 47
4.5.5.1 Company footprint 47
4.5.5.2 Region footprint 48
4.5.5.3 Type footprint 49
4.5.5.4 Route of insertion footprint 50
4.5.5.5 Application footprint 51
4.5.5.6 End-user footprint 52
4.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 53
4.6.1 PROGRESSIVE COMPANIES 53
4.6.2 RESPONSIVE COMPANIES 53
4.6.3 DYNAMIC COMPANIES 53
4.6.4 STARTING BLOCKS 53
4.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 55
4.6.5.1 Detailed list of key startup/SME players 55
4.6.5.2 Competitive benchmarking of key emerging players/startups 55
4.7 COMPANY VALUATION & FINANCIAL METRICS 56
4.7.1 FINANCIAL METRICS 56
4.7.2 COMPANY VALUATION 56
4.8 BRAND/PRODUCT COMPARISON 57
4.9 COMPETITIVE SCENARIO 58
4.9.1 PRODUCT LAUNCHES & APPROVALS 58
4.9.2 DEALS 59
4.9.3 OTHER DEVELOPMENTS 59
5 COMPANY PROFILES 60
5.1 KEY PLAYERS 60
5.1.1 BECTON, DICKINSON AND COMPANY 60
5.1.1.1 Business overview 60
5.1.1.2 Products offered 61
5.1.1.3 Recent developments 66
5.1.1.3.1 Deals 66
5.1.1.4 MnM view 67
5.1.1.4.1 Key strengths 67
5.1.1.4.2 Strategic choices 67
5.1.1.4.3 Weaknesses & competitive threats 67
5.1.2 TELEFLEX INCORPORATED 68
5.1.2.1 Business overview 68
5.1.2.2 Products offered 69
5.1.2.3 Recent developments 72
5.1.2.3.1 Product launches 72
5.1.2.3.2 Other developments 73
5.1.2.4 MnM view 73
5.1.2.4.1 Key strengths 73
5.1.2.4.2 Strategic choices 73
5.1.2.4.3 Weaknesses & competitive threats 73
5.1.3 ICU MEDICAL 74
5.1.3.1 Business overview 74
5.1.3.2 Products offered 75
5.1.3.3 Recent developments 78
5.1.3.3.1 Deals 78
5.1.3.4 MnM view 78
5.1.3.4.1 Key strengths 78
5.1.3.4.2 Strategic choices 78
5.1.3.4.3 Weaknesses & competitive threats 78
5.1.4 NIPRO 79
5.1.4.1 Business overview 79
5.1.4.2 Products offered 80
5.1.4.3 MnM view 81
5.1.4.3.1 Key strengths 81
5.1.4.3.2 Strategic choices 81
5.1.4.3.3 Weaknesses & competitive threats 81
5.1.5 ANGIODYNAMICS, INC. 82
5.1.5.1 Business overview 82
5.1.5.2 Products offered 83
5.1.5.3 Recent developments 84
5.1.5.3.1 Product approvals 84
5.1.5.3.2 Deals 84
5.1.5.4 MnM view 85
5.1.5.4.1 Key strengths 85
5.1.5.4.2 Strategic choices 85
5.1.5.4.3 Weaknesses & competitive threats 85
5.1.6 VYGON 86
5.1.6.1 Business overview 86
5.1.6.2 Products offered 86
5.1.7 TERUMO CORPORATION 93
5.1.7.1 Business overview 93
5.1.7.2 Products offered 95
5.1.8 MEDTRONIC PLC 96
5.1.8.1 Business overview 96
5.1.8.2 Products offered 97
5.1.9 COOK 99
5.1.9.1 Business overview 99
5.1.9.2 Products offered 99
5.1.10 B. BRAUN SE 101
5.1.10.1 Business overview 101
5.1.10.2 Products offered 102
5.1.10.3 Recent developments 107
5.1.10.3.1 Product launches & approvals 107
5.1.10.3.2 Deals 108
5.1.11 MERIT MEDICAL SYSTEMS, INC. 109
5.1.11.1 Business overview 109
5.1.11.2 Products offered 110
5.1.11.3 Recent developments 111
5.1.11.3.1 Deals 111
5.1.12 AMECATH 112
5.1.12.1 Business overview 112
5.1.12.2 Products offered 112
5.1.13 MEDICAL COMPONENTS, INC. 115
5.1.13.1 Business overview 115
5.1.13.2 Products offered 115
?
5.1.14 HEALTHLINE MEDICAL PRODUCTS 118
5.1.14.1 Business overview 118
5.1.14.2 Products offered 118
5.1.15 ACCESS VASCULAR, INC. 120
5.1.15.1 Business overview 120
5.1.15.2 Products offered 120
5.2 OTHER PLAYERS 121
5.2.1 ARGON MEDICAL DEVICES 121
5.2.2 PAKUMEDMEDICAL PRODUCTS GMBH 122
5.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD. 123
5.2.4 PFM MEDICAL GMBH 124
5.2.5 MEDI-TECH DEVICES PVT. LTD. 125
5.2.6 KIMAL 126
5.2.7 POLYMEDICURE 127
5.2.8 DELTAMED 128
5.2.9 NEWTECH MEDICAL DEVICES PVT. LTD. 129
5.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD. 130
6 APPENDIX 131
6.1 RESEARCH METHODOLOGY 131
6.1.1 RESEARCH DATA 131
6.1.1.1 Secondary data 131
6.1.1.2 Primary data 132
6.1.2 RESEARCH LIMITATIONS 134
6.1.3 RISK ANALYSIS 134
6.2 COMPANY EVALUATION MATRIX: METHODOLOGY 135
6.3 AUTHOR DETAILS 138
TABLE 1 VASCULAR ACCESS DEVICES MARKET: ROLE IN ECOSYSTEM 31
TABLE 2 VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF
KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026 37
TABLE 3 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN
VASCULAR ACCESS DEVICES MARKET 40
TABLE 4 VASCULAR ACCESS DEVICES MARKET: DEGREE OF COMPETITION 43
TABLE 5 VASCULAR ACCESS DEVICES MARKET: REGION FOOTPRINT 48
TABLE 6 VASCULAR ACCESS DEVICES MARKET: TYPE FOOTPRINT 49
TABLE 7 VASCULAR ACCESS DEVICES MARKET: ROUTE OF INSERTION FOOTPRINT 50
TABLE 8 VASCULAR ACCESS DEVICES MARKET: APPLICATION FOOTPRINT 51
TABLE 9 VASCULAR ACCESS DEVICES MARKET: END-USER FOOTPRINT 52
TABLE 10 VASCULAR ACCESS DEVICES MARKET:
DETAILED LIST OF KEY STARTUP/SME PLAYERS 55
TABLE 11 VASCULAR ACCESS DEVICES MARKET:
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 55
TABLE 12 VASCULAR ACCESS DEVICES MARKET:
PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025 58
TABLE 13 VASCULAR ACCESS DEVICES MARKET: DEALS, JANUARY 2021-JANUARY 2025 59
TABLE 14 VASCULAR ACCESS DEVICES MARKET:
OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 59
TABLE 15 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 60
TABLE 16 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 61
TABLE 17 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021-JANUARY 2025 66
TABLE 18 TELEFLEX INCORPORATED: COMPANY OVERVIEW 68
TABLE 19 TELEFLEX INCORPORATED: PRODUCTS OFFERED 69
TABLE 20 TELEFLEX INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025 72
TABLE 21 TELEFLEX INCORPORATED: OTHER DEVELOPMENTS,
JANUARY 2021-JANUARY 2025 73
TABLE 22 ICU MEDICAL: COMPANY OVERVIEW 74
TABLE 23 ICU MEDICAL: PRODUCTS OFFERED 75
TABLE 24 ICU MEDICAL: DEALS, JANUARY 2021-JANUARY 2025 78
TABLE 25 NIPRO: COMPANY OVERVIEW 79
TABLE 26 NIPRO: PRODUCTS OFFERED 80
TABLE 27 ANGIODYNAMICS, INC.: COMPANY OVERVIEW 82
TABLE 28 ANGIODYNAMICS, INC.: PRODUCTS OFFERED 83
TABLE 29 ANGIODYNAMICS, INC.: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025 84
TABLE 30 ANGIODYNAMICS, INC.: DEALS, JANUARY 2021-JANUARY 2025 84
TABLE 31 VYGON: COMPANY OVERVIEW 86
TABLE 32 VYGON: PRODUCTS OFFERED 86
TABLE 33 TERUMO CORPORATION: COMPANY OVERVIEW 93
TABLE 34 TERUMO CORPORATION: PRODUCTS OFFERED 95
TABLE 35 MEDTRONIC PLC: COMPANY OVERVIEW 96
TABLE 36 MEDTRONIC PLC: PRODUCTS OFFERED 97
TABLE 37 COOK: COMPANY OVERVIEW 99
TABLE 38 COOK: PRODUCTS OFFERED 99
TABLE 39 B. BRAUN SE: COMPANY OVERVIEW 101
TABLE 40 B. BRAUN SE: PRODUCTS OFFERED 102
TABLE 41 B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021-JANUARY 2025 107
TABLE 42 B. BRAUN SE: DEALS, JANUARY 2021-JANUARY 2025 108
TABLE 43 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 109
TABLE 44 MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED 110
TABLE 45 MERIT MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021-JANUARY 2025 111
TABLE 46 AMECATH: COMPANY OVERVIEW 112
TABLE 47 AMECATH: PRODUCTS OFFERED 112
TABLE 48 MEDICAL COMPONENTS, INC.: COMPANY OVERVIEW 115
TABLE 49 MEDICAL COMPONENTS, INC.: PRODUCTS OFFERED 115
TABLE 50 HEALTHLINE MEDICAL PRODUCTS: COMPANY OVERVIEW 118
TABLE 51 HEALTHLINE MEDICAL PRODUCTS: PRODUCTS OFFERED 118
TABLE 52 ACCESS VASCULAR, INC.: COMPANY OVERVIEW 120
TABLE 53 ACCESS VASCULAR, INC.: PRODUCTS OFFERED 120
TABLE 54 ARGON MEDICAL DEVICES: COMPANY OVERVIEW 121
TABLE 55 PAKUMEDMEDICAL PRODUCTS GMBH: COMPANY OVERVIEW 122
TABLE 56 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 123
TABLE 57 PFM MEDICAL GMBH: COMPANY OVERVIEW 124
TABLE 58 MEDI-TECH DEVICES PVT. LTD.: COMPANY OVERVIEW 125
TABLE 59 KIMAL: COMPANY OVERVIEW 126
TABLE 60 POLYMEDICURE: COMPANY OVERVIEW 127
TABLE 61 DELTAMED: COMPANY OVERVIEW 128
TABLE 62 NEWTECH MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW 129
TABLE 63 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW 130
TABLE 64 VASCULAR ACCESS DEVICES MARKET: RISK ANALYSIS 134
FIGURE 1 CENTRAL VENOUS ACCESS DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD 14
FIGURE 2 TUNNELED CATHETERS TO GROW AT HIGHEST CAGR IN
CENTRAL VENOUS ACCESS DEVICES MARKET FROM 2024 TO 2030 15
FIGURE 3 IMPLANTABLE POWER INJECTABLE PORTS TO REGISTER HIGHEST GROWTH RATE IN IMPLANTABLE PORTS MARKET DURING STUDY PERIOD 15
FIGURE 4 PERIPHERAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR
LARGEST MARKET SHARE DURING FORECAST PERIOD 16
FIGURE 5 PERIPHERAL INTRAVENOUS CATHETERS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD 17
FIGURE 6 INTRAVENOUS ROUTE OF INSERTION TO HOLD LARGEST MARKET SHARE
FROM 2024 TO 2030 17
FIGURE 7 DRUG ADMINISTRATION TO COMMAND LARGEST SHARE IN
APPLICATIONS SEGMENT 18
FIGURE 8 CHEMOTHERAPY TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD 19
FIGURE 9 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING
FORECAST PERIOD 19
FIGURE 10 PUBLIC HOSPITALS TO COMMAND LARGER SHARE OF HOSPITALS MARKET DURING FORECAST PERIOD 20
FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL MARKET FOR
VASCULAR ACCESS DEVICES 21
FIGURE 12 VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 22
FIGURE 13 VASCULAR ACCESS DEVICES MARKET: VALUE CHAIN ANALYSIS 30
FIGURE 14 VASCULAR ACCESS DEVICES MARKET: ECOSYSTEM ANALYSIS 30
FIGURE 15 VASCULAR ACCESS DEVICES MARKET: SUPPLY CHAIN ANALYSIS 32
FIGURE 16 VASCULAR ACCESS DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS 33
FIGURE 17 NUMBER OF PATENT PUBLICATIONS (JANUARY 2014-DECEMBER 2024) 35
FIGURE 18 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR
VASCULAR ACCESS DEVICE PATENTS (JANUARY 2014?DECEMBER 2024) 36
FIGURE 19 TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR ACCESS DEVICES
(JANUARY 2014? DECEMBER 2024) 37
FIGURE 20 VASCULAR ACCESS DEVICES MARKET: TRENDS AND
DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS 38
FIGURE 21 VASCULAR ACCESS DEVICES MARKET: IMPACT OF AI/GEN AI 39
FIGURE 22 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS
DEVICES MARKET (2019-2023) 42
FIGURE 23 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS
DEVICES MARKET (2023) 43
FIGURE 24 VASCULAR ACCESS DEVICES MARKET:
COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 46
FIGURE 25 VASCULAR ACCESS DEVICES MARKET: COMPANY FOOTPRINT 47
FIGURE 26 VASCULAR ACCESS DEVICES MARKET:
COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 54
FIGURE 27 EV/EBITDA OF KEY VENDORS 56
FIGURE 28 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND
5-YEAR STOCK BETA OF KEY VENDORS 56
FIGURE 29 VASCULAR ACCESS DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 57
FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 61
FIGURE 31 TELEFLEX INCORPORATED: COMPANY SNAPSHOT 69
FIGURE 32 ICU MEDICAL: COMPANY SNAPSHOT 75
FIGURE 33 NIPRO: COMPANY SNAPSHOT 80
FIGURE 34 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT 83
FIGURE 35 TERUMO CORPORATION: COMPANY SNAPSHOT 94
FIGURE 36 MEDTRONIC PLC: COMPANY SNAPSHOT 97
FIGURE 37 B. BRAUN SE: COMPANY SNAPSHOT 102
FIGURE 38 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT 110
FIGURE 39 VASCULAR ACCESS DEVICES MARKET: RESEARCH DESIGN 131
FIGURE 40 VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES 132
FIGURE 41 VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES 133
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security